Is capecitabine a targeted drug

Capecitabine is not a targeted drug.

Capecitabine is a chemotherapeutic drug. It can be converted into cytotoxic substances in vivo, which can interfere with the nucleic acid metabolism of cancer cells, thus inhibiting the growth and proliferation of cancer cells. Secondly, it has a certain selectivity for tumor cells, but this selectivity is not precisely targeted at specific molecular targets like targeted drugs, but is based on its metabolic activation characteristics in tumor cells. Capecitabine is often used in combination with other chemotherapy drugs or alone in the treatment of a variety of malignant tumors, such as breast cancer, gastrointestinal tumors, etc., which can effectively control the progression of tumors.

Although capecitabine is not a targeted drug, it still plays an important role in tumor treatment and plays a positive role in improving the survival and quality of life of patients. During the use process, it is necessary to pay close attention to the possible adverse reactions, such as gastrointestinal reactions, hand-foot syndrome, etc., and formulate and adjust individualized treatment plans according to the specific conditions of patients.